Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 965 | 1083 | 965 | 593 | - | - |
Fund Return | -3.47% | 8.34% | -3.47% | -15.97% | - | - |
Place in category | 168 | 164 | 168 | 131 | - | - |
% in Category | 80 | 74 | 80 | 84 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A acc USD he | 16.8B | 2.61 | 1.40 | 3.76 | ||
JPI Global Income Fund A div USD he | 16.8B | 2.62 | 1.41 | 3.77 | ||
JPI Global Income Fund A mth USD he | 16.8B | 2.60 | 1.38 | 3.75 | ||
JPI Global Income Fund C acc USD he | 16.8B | 2.78 | 2.07 | 4.43 | ||
Global Income Fund D div USD hedged | 16.8B | 2.52 | 1.02 | 3.38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 111.66M | 4.88 | -4.60 | 3.64 | ||
Pictet Biotech R USD | 1.56B | -18.92 | 4.74 | 6.44 | ||
Pictet Biotech PUSD | 1.56B | -18.50 | 5.47 | 7.18 | ||
Equities L Biotechnology Class I US | 1.52B | 2.72 | 2.18 | 7.26 | ||
Equities L Biotechnology Class R US | 1.52B | 2.99 | 2.98 | 7.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.31 | 154.33 | +2.06% | |
Vertex | US92532F1003 | 3.18 | 410.24 | +1.92% | |
Amgen | US0311621009 | 3.12 | 300.30 | +0.27% | |
Novartis | CH0012005267 | 3.08 | 89.78 | +1.91% | |
Biomarin Pharma | US09061G1013 | 3.04 | 82.58 | +0.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | Sell |
Summary | Strong Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review